Torrent Pharmaceuticals reports consolidated net loss of Rs 152 crore in Q4

21 May 2019 Evaluate

Torrent Pharmaceuticals has reported results for the fourth quarter and year ended March 31, 2019. 

The company has reported a fall of 25.45% in its net profit at Rs 164 crore for the quarter ended March 31, 2019 as compared to Rs 220 crore for the same quarter in the previous year. However, total income of the company increased by 14.53% at Rs 1,584 crore for quarter under review as compared to Rs 1,383 crore for the quarter ended March 31, 2018.

On consolidated basis, the company has reported a net loss of Rs 152 crore for the quarter ended March 31, 2019 against net profit of Rs 228 crore for the corresponding quarter in the FY18. However, total consolidated income of the company rose by 7.03% at Rs 1,873 crore for quarter under review as compared to Rs 1,750 crore for the same quarter ended previous year.

For the year ended March 31, 2019, the company has posted a rise of 54.56% in its net profit at Rs 745 crore as compared to Rs 482 crore for the previous year. Total income of company increased 34.27% at Rs 6,144 crore for year under review as compared to Rs 4,576 crore for year ended March 31, 2018.

For the year ended March 31, 2019, on the consolidated basis, the company has posted fall of 35.69% in its net profit at Rs 436 crore as compared to Rs 678 crore for the previous year. However, total income of company increased by 23.70% at Rs 7,730 crore for year under review as compared to Rs 6,249 crore for year ended March 31, 2018.

Torrent Pharma Share Price

3926.95 -97.05 (-2.41%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×